Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Babu

Showing results (231-240 of 252) with videos related to

Pageof 26
Sort By:
The Journal of Infectious Diseases|January 8, 2025
Effectiveness of mRNA COVID-19 Vaccines and Hybrid Immunity in Preventing SARS-CoV-2 Infection and Symptomatic COVID-19 Among Adults in the United StatesLeora R Feldstein, Jasmine Ruffin, Ryan E Wiegand, et al.
BMJ Open|July 14, 2023
CASCADIA: a prospective community-based study protocol for assessing SARS-CoV-2 vaccine effectiveness in children and adults using a remote nasal swab collection and web-based survey designTara M Babu, Leora R Feldstein, Sharon Saydah, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 14, 2025
Household Transmission and Genomic Diversity of Respiratory Syncytial Virus (RSV) in the United States, 2022-2023Sarah N Cox, Pavitra Roychoudhury, Collrane Frivold, et al.
Infection|August 3, 2022
COVID-19 associated multisystemic mucormycosis from India: a multicentric retrospective study on clinical profile, predisposing factors, cumulative mortality and factors affecting outcomeMonalisa Sahu, Milap Shah, Venkateswara R Mallela, et al.
Medrxiv : the Preprint Server for Health Sciences|August 17, 2021
SARS-CoV-2 Seroprevalence and Drug Use in Trauma Patients from Six Sites in the United StatesTran B Ngo, Maria Karkanitsa, Kenneth M Adusei, et al.
Vaccine|August 24, 2025
Parental intent to vaccinate children with the updated 2023-2024 COVID-19 vaccineHolly C Groom, Jennifer L Kuntz, Alexandra M Varga, et al.
Journal of the Pediatric Infectious Diseases Society|December 10, 2024
Protection From COVID-19 Vaccination and Prior SARS-CoV-2 Infection Among Children Aged 6 Months-4 Years, United States, September 2022-April 2023Leora R Feldstein, Jasmine Ruffin, Ryan Wiegand, et al.
JAMA|February 6, 2024
Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 YearsLeora R Feldstein, Amadea Britton, Lauren Grant, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2023
Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical TrialAngela R Branche, Nadine G Rouphael, Cecilia Losada, et al.
Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical TrialNadine G Rouphael, Angela R Branche, David J Diemert, et al.
Pageof 26

Showing results (231-240 of 252) with videos related to

Sort By:
Pageof 26
The Journal of Infectious Diseases|January 8, 2025
Effectiveness of mRNA COVID-19 Vaccines and Hybrid Immunity in Preventing SARS-CoV-2 Infection and Symptomatic COVID-19 Among Adults in the United StatesLeora R Feldstein, Jasmine Ruffin, Ryan E Wiegand, et al.
BMJ Open|July 14, 2023
CASCADIA: a prospective community-based study protocol for assessing SARS-CoV-2 vaccine effectiveness in children and adults using a remote nasal swab collection and web-based survey designTara M Babu, Leora R Feldstein, Sharon Saydah, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 14, 2025
Household Transmission and Genomic Diversity of Respiratory Syncytial Virus (RSV) in the United States, 2022-2023Sarah N Cox, Pavitra Roychoudhury, Collrane Frivold, et al.
Infection|August 3, 2022
COVID-19 associated multisystemic mucormycosis from India: a multicentric retrospective study on clinical profile, predisposing factors, cumulative mortality and factors affecting outcomeMonalisa Sahu, Milap Shah, Venkateswara R Mallela, et al.
Medrxiv : the Preprint Server for Health Sciences|August 17, 2021
SARS-CoV-2 Seroprevalence and Drug Use in Trauma Patients from Six Sites in the United StatesTran B Ngo, Maria Karkanitsa, Kenneth M Adusei, et al.
Vaccine|August 24, 2025
Parental intent to vaccinate children with the updated 2023-2024 COVID-19 vaccineHolly C Groom, Jennifer L Kuntz, Alexandra M Varga, et al.
Journal of the Pediatric Infectious Diseases Society|December 10, 2024
Protection From COVID-19 Vaccination and Prior SARS-CoV-2 Infection Among Children Aged 6 Months-4 Years, United States, September 2022-April 2023Leora R Feldstein, Jasmine Ruffin, Ryan Wiegand, et al.
JAMA|February 6, 2024
Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 YearsLeora R Feldstein, Amadea Britton, Lauren Grant, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2023
Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical TrialAngela R Branche, Nadine G Rouphael, Cecilia Losada, et al.
Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical TrialNadine G Rouphael, Angela R Branche, David J Diemert, et al.
Pageof 26